153 related articles for article (PubMed ID: 36942088)
1. Feasibility of biology-guided radiotherapy for metastatic renal cell carcinoma driven by PSMA PET imaging.
Gaudreault M; Chang D; Hardcastle N; McIntosh L; Jackson P; Kron T; Udovicich C; Hofman MS; Siva S
Clin Transl Radiat Oncol; 2023 May; 40():100608. PubMed ID: 36942088
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of biology-guided radiotherapy using PSMA-PET to boost to dominant intraprostatic tumour.
Gaudreault M; Chang D; Hardcastle N; Jackson P; Kron T; Hofman MS; Siva S
Clin Transl Radiat Oncol; 2022 Jul; 35():84-89. PubMed ID: 35662883
[TBL] [Abstract][Full Text] [Related]
3. Utility of Biology-Guided Radiotherapy to
Gaudreault M; Chang D; Hardcastle N; Jackson P; Kron T; Hanna GG; Hofman MS; Siva S
Front Oncol; 2022; 12():854589. PubMed ID: 35494012
[TBL] [Abstract][Full Text] [Related]
4. Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer.
Gaudreault M; Chang D; Hardcastle N; Jackson P; Kron T; Hofman MS; Siva S
Front Oncol; 2023; 13():1134884. PubMed ID: 36994211
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Online Prostate-Specific Membrane Antigen and Positron Emission Tomography-Guided Radiation Therapy for Oligometastatic Prostate Cancer.
Hrinivich WT; Phillips R; Da Silva AJ; Radwan N; Gorin MA; Rowe SP; Pienta KJ; Pomper MG; Wong J; Tran PT; Kang-Hsin Wang K
Adv Radiat Oncol; 2020; 5(2):260-268. PubMed ID: 32280826
[TBL] [Abstract][Full Text] [Related]
7. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma.
Udovicich C; Callahan J; Bressel M; Ong WL; Perera M; Tran B; Azad A; Haran S; Moon D; Chander S; Shaw M; Eapen R; Goad J; Lawrentschuk N; Murphy DG; Hofman M; Siva S
Eur Urol Open Sci; 2022 Oct; 44():60-68. PubMed ID: 36185587
[TBL] [Abstract][Full Text] [Related]
8. Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [
Yin Y; Campbell SP; Markowski MC; Pierorazio PM; Pomper MG; Allaf ME; Rowe SP; Gorin MA
Mol Imaging Biol; 2019 Jun; 21(3):567-573. PubMed ID: 30218388
[TBL] [Abstract][Full Text] [Related]
9. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted ¹⁸F-DCFPyL PET/CT.
Rowe SP; Gorin MA; Hammers HJ; Som Javadi M; Hawasli H; Szabo Z; Cho SY; Pomper MG; Allaf ME
Ann Nucl Med; 2015 Dec; 29(10):877-82. PubMed ID: 26286635
[TBL] [Abstract][Full Text] [Related]
10. Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT).
Tariq A; McGeorge S; Pearce A; Rhee H; Wood S; Kyle S; Marsh P; Raveenthiran S; Wong D; McBean R; Westera J; Dunglison N; Esler R; Navaratnam A; Yaxley J; Thomas P; Pattison DA; Roberts MJ
Urol Oncol; 2022 Jun; 40(6):276.e1-276.e9. PubMed ID: 35466037
[TBL] [Abstract][Full Text] [Related]
11. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
[TBL] [Abstract][Full Text] [Related]
12. The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer.
Evangelista L; Basso U; Maruzzo M; Novara G
Eur Urol Focus; 2020 Jan; 6(1):146-150. PubMed ID: 30120074
[TBL] [Abstract][Full Text] [Related]
13. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
[TBL] [Abstract][Full Text] [Related]
14. A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
Ahn T; Roberts MJ; Abduljabar A; Joshi A; Perera M; Rhee H; Wood S; Vela I
Mol Imaging Biol; 2019 Oct; 21(5):799-807. PubMed ID: 30617728
[TBL] [Abstract][Full Text] [Related]
15. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
16. Utility of
Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
[TBL] [Abstract][Full Text] [Related]
17. A detailed process map for clinical workflow of a new biology-guided radiotherapy (BgRT) machine.
Hwang MS; Lalonde R; Huq MS
J Appl Clin Med Phys; 2022 Jun; 23(6):e13606. PubMed ID: 35536773
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
19. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of
Natarajan A; Khan S; Liang X; Nguyen H; Das N; Anders D; Malik N; Oderinde OM; Chin FT; Rosenthal E; Pratx G
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):927-934. PubMed ID: 36669541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
